Using UvrABC incision in combination with ligationmediated PCR (LMPCR) we have previously shown that benzo(a)pyrene diol epoxide (BPDE) adduct formation along the nontranscribed strand of the human p53 gene is highly selective; the preferential binding sites coincide with the major mutation hotspots found in human lung cancers. Both sequence-dependent adduct formation and repair may contribute to these mutation hotspots in tumor tissues. To test this possibility, we have extended our previous studies by mapping the BPDE adduct distribution in the transcribed strand of the p53 gene and quantifying the rates of repair for individual damaged bases in exons 5, 7, and 8 for both DNA strands of this gene in normal human ®broblasts. We found that: (i) on both strands, BPDE adducts preferentially form at CpG sequences, and (ii) repair of BPDE adducts in the transcribed DNA strand is consistently faster than repair of adducts in the nontranscribed strand, while repair at the major damage hotspots (guanines at codons 157, 248 and 273) in the nontranscribed strand is two to four times slower than repair at other damage sites. These results strongly suggest that both preferential adduct formation and slow repair lead to hotspots for mutations at codons 157, 248 and 273, and that the strand bias of bulky adduct repair is primarily responsible for the strand bias of G to T transversion mutations observed in the p53 gene in human cancers.
Introduction
The tumor suppressor p53 functions as a guardian of the genomic integrity of the cell; it coordinates the cellular responses to DNA damage by inducing either cell cycle arrest to increase the opportunity for repair of damaged DNA, or programmed cell death to sacri®ce cells with massive and irreparable DNA damage (Hollstein et al., 1991; Levine et al., 1991; Harris, 1993; Levine, 1997; Vogelstein and Kinzler, 1992) . Mutation of the p53 gene is one of the most common features in neoplastic transformation (Hollstein et al., 1991 (Hollstein et al., , 1996 Jones et al., 1991; Harris and Hollstein, 1993; Greenblatt et al., 1994; Harris 1996; Ruddon, 1995) . It has been found that more than 50% of human cancers have mutations in the p53 gene with these mutations occurring at dierent stages during cancer development (Hollstein et al., 1991 (Hollstein et al., , 1996 Jones et al., 1991; Harris and Hollstein, 1993; Greenblatt et al., 1994; Harris, 1996; Ruddon, 1995) .
The p53 mutations found in human cancers are of various types, and occur at dierent sequences (Greenblatt et al., 1994; Hollstein et al., 1996) . More than 200 mutated codons of the p53 gene have been identi®ed in various human cancers, and the types of mutations often seem to bear the signature of the etiological agent (Greenblatt et al., 1994; Hollstein et al., 1996) . One of the most notable examples is lung cancer. In lung cancers from cigarette smokers, 40% of p53 gene mutations are G to T transversions and 24% are G to A transitions, while in lung cancers from nonsmokers, only 13% of mutations in this gene are G to T transversions and more than 60% are G to A transitions (Greenblatt et al., 1994; Hollstein et al., 1996) . Furthermore, 90% of the G to T transversion mutations in the p53 gene in lung cancers occur on the nontranscribed strand. It has been well established that most bulky carcinogen-induced mutations are G to T transversions, while most spontaneous mutations are G to A transitions (presumably arising by deamination of 5-C methylated cytosine at CpG sites) (Jones et al., 1991) . In lung cancers of cigarette smokers p53 gene mutations are concentrated at codons 157, 179, 245, 248, 273 and 282 (Greenblatt et al., 1994; Hollstein et al., 1996) . In contrast, no mutation hotspots are observed in lung cancers from nonsmokers, and only a single mutation hotspot at codon 249 is observed in radon-associated lung cancers (Greenblatt et al., 1994; Hollstein et al., 1996) . Together, these results strongly suggest that mutations in the p53 gene in cigarette smokers result from DNA damage from exogenous agents.
Benzo [a] pyrene (BP) is a major carcinogen of cigarette smoke as well as an environmental pollutant; in vivo, BP is metabolically activated to BPDE, which binds to nucleophilic DNA at the exocylic amine of guanine (for a review see, Harvey, 1991) . Results obtained in a number of animal model systems have strongly suggested that BPDE induced DNA damage initiates carcionogenesis (for review, see Harvey, 1991; Harvey, 1981; Weinstein, 1981; Pelkonen and Nebert, 1982; Beland and Poirier, 1989) . The binding BPDE to DNA is greatly aected by DNA sequence context and nucleosome structure (Kaneko and Cerutti, 1982; Boles and Hogan, 1984; Osborne, 1990; Tang et al., 1992; Smith and MacLeod, 1993; Thrall et al., 1994) . Recently, using UvrABC incision and LMPCR methods to map BPDE-DNA adduct distribution in the human p53 gene in cultered HeLa cells, normal human ®broblasts and bronchial epithelial cells, we have found that BPDE-guanine adducts form preferentially at codons 157, 248 and 273 (Denissenko et al., 1996) ; these preferential binding sites correspond exactly to the major mutational hotspot sites found in smoking-associated human lung cancers (Greenblatt et al., 1994; Hollstein et al., 1996) .
In the present work we have further investigated BPDE-DNA adduct formation and repair in cultured human cells, at single nucleotide resolution, and have extended our understanding of the relationship between BPDE induced DNA damage, repair and the mutational hotspots and the strand bias of G to T transversion mutations in the p53 gene in lung cancer.
Results
BPDE preferentially binds CpG sequences in both the transcribed and nontranscribed strands of the p53 gene Previously, using UvrABC-LMPCR methods, we have shown preferential DNA adduct formation by BPDE at speci®c sites in codons 157, 248 and 273 of the nontranscribed strand of the human p53 gene; these sites correspond to the major mutational hotspots found in lung cancer (Denissenko et al., 1996) . Our more recent studies have demonstrated that all such preferential BPDE binding sites are at CpG sequences and that cytosine methylation at these sequences promotes this preferential binding (Denissenko et al., 1997) . These results suggested that one might also expect preferential binding of BPDE at CpG sites in the transcribed strand opposite to hotspot binding sites in the nontranscribed strand of the p53 gene, since in vivo maintenance methylation mechanisms maintain symmetrical methylation of cytosines on both DNA strands at such CpG sites (Tornaletti and Pfeifer, 1995) . To test this possibility we have used UvrABC incision in combination with LPMCR to map the distribution of BPDE adducts along DNA sequences encompassing exons 5 ± 8 of the transcribed strand of the p53 gene, in cultured human cells treated with 2 mM of BPDE. Results presented in Figure 1 ± 3 show that most CpG sites in the transcribed strand (codons 156, 158, and 170 in Figure 1b , lane 6; codons 244, and 248 in Figure 2b , lane 6; codons 273, 282, 283, and 290 in Figure 3b , lane 6), including those sites opposite to mutational hotspot sites in the nontranscribed strand (codons 157, 158, 245, 248, 273 and 282) , are indeed preferential BPDE binding sites. It is also worth noting that although guanines on the nontranscribed strand of codons 158, 245, and 282 have rather weak BPDE binding anities, guanines on the transcribed strand at or near these codon positions (158, 244 and 282) have relatively high BPDE binding anities. The cause for such dierences in BPDE binding between transcribed and nontranscribed strands is unknown. It is possible that at such sequences the transcribed strand may face out of the nucleosome, while the nontranscribed strand may face into the nucleosome, therefore, BPDE binding in the latter, but not in the former, will be interfered with by the nuclear proteins. Considerable BPDE binding, either in one or both strands, was also observed at codons 170, 242, 283, and 290. While signi®cant numbers of mutations have been found at codons 242 and 283 in lung cancer, very few mutations occur at codons 170 and 290. It is possible that BPDEadduct-induced mutations that result in amino acid changes at codons 170 and 290 may not aect normal, wild-type function of the p53 gene product. Indeed, a G to T transversion (ACG to ACT) at codon 170 would lead to a silent mutation.
Repair of BPDE adducts formed at mutational hotspots is two to four times slower for sites in the nontranscribed strand than sites in the transcribed strand It has been shown that 90% of all G to T transversion mutations found in the p53 gene of lung cancers in cigarette smokers occur at G's on the nontranscribed strand of this gene (Greenblatt et al., 1994; Hollstein et al., 1996) . These results suggest that either BPDE-DNA adduct formation is more ecient in the nontranscribed strand than in the transcribed strand, or removal of adducts from the nontranscribed strand is much slower. While the results in Figures 1 ± 3 show that BPDE binds strongly at individual CpG sites on both the nontranscribed strand and transcribed strand, the nature of LMPCR methodology precludes a precise assessment of the relative extent of binding for the two DNA strands. Thus, in order to distinguish these two possibilities, we have determined the time courses for BPDE-DNA adduct repair in both the transcribed and nontranscribed strands of the p53 gene in cultured human cells treated with 2 mM of BPDE. Results presented in Figures  1 ± 3 clearly demonstrate that at mutational hotspots in codons 157, 248, 273 and 282, repair of BPDE-DNA adducts on the nontranscribed strand is signi®cantly slower than repair of adducts on the transcribed strand. While repair of BPDE adducts in the nontranscribed strand is generally slower than in the transcribed strand, much greater sequence-dependent variation in repair eciency is seen on the nontranscribed strand than in the transcribed strand. BPDE adducts on the nontranscribed strand in codons 181, 244 and 276 are repaired with a faster rate than those at mutational hotspot sites in codons 157, 248, 273 and 282. In contrast, repair of BPDE adducts in the transcribed strand at these codon positions shows much less sequence-dependence; regardless of the initial eciency of formation, all of the adducts on the transcribed strand appear to be rapidly and uniformly repaired after 8 h.
The repair kinetics for BPDE adducts formed at various sites along both the transcribed and nontranscribed strands of the p53 gene have been quanti®ed for exons 5, 7 and 8 of the p53 gene. Figure 4 shows, for each BPDE adduct site the time period required for removal of 50% of the BPDE adducts initially formed at that site. At most sites on the transcribed strand it takes only *5 h to remove 50% of the BPDE adducts, except at codon 252 where *10 h is required. In contrast, it generally takes 10 ± 20 h, to remove 50% of the BPDE adducts from sites on the nontranscribed strand, except at codon 181, where it takes only 5 h.
Discussion
Two factors which may contribute to site-and sequence-dependent mutations are: the frequency of DNA damage at a particular site, and the eciency of repair of damage formed at that site. Using UvrABC-LMPCR methods, we have found that the chemically activated cigarette smoke component BPDE forms DNA adducts preferentially at sites along the nontranscribed strand of the p53 gene which had been previously identi®ed as mutational hotspots in human lung cancer (Denissenko et al., 1996) . Interestingly all of these preferential BPDE binding sites are located at CpG sequences. Our further studies have indicated that cytosine methylation at such CpG sequences is the major factor leading to this enhanced BPDE-DNA binding (Denissenko et al., 1997) . We expected that BPDE should also preferentially form adducts in the transcribed strand at these mutational hotspot sites in the p53 gene since both DNA strands have the same methylation pattern at such sites (Tornaletti and Pfeifer, 1995) . The results we present in this work show that BPDE indeed forms DNA adducts at these mutational hotspots (codons 157, 248 and 273), on both the transcribed and nontranscribed strands of the p53 gene. However, we found that repair of BPDE adducts formed in the nontranscribed strand at these mutational hotspots is two to four times slower than repair of adducts formed in the transcribed strand. Both, preferential binding and slow repair of BPDE adducts formed in the nontranscribed strand at mutational hotspot sites in the p53 gene may be the major reason leading to the strand-bias of G to T transversion in lung cancer (Greenblatt et al., 1994) .
Transcribed strand biased repair of cyclobutane pyrimidine dimers and bulky chemicals induced DNA adducts has been observed in human cells (Hanawalt, 1994; Hanawalt et al., 1994; Bohr, 1991 been reported that BPDE-adducts are more eciently repaired in the transcribed strand than in the nontranscribed strand of human HPRT gene (Chen et al., 1992) , these adducts are repaired with equal eciency in both strands of DHFR and APRT genes in cultured Chinese hamster ovary cells (Tang et al., 1994) . BPDE binds not only to nucleic acids but also to nucleophilic proteins; BPDE-DNA adducts have been shown to bind to transcription factors (Treiber et al., 1994; Butler et al., 1997) . Such interactions may interfere with initiation of transcription, and the initiation of transcription of individual genes might be subject to dierent degrees of inhibition by the same chemical. This might explain dierences in the extent of strand biased repair observed for individual genes.
Other factors, such as the concentrations of the carcinogens used (which might dierentially aect transcription initiation), or regional dierences in the relative eectiveness of global repair versus transcription coupled repair mechanisms, may also play important roles in determining strand bias of repair. In general, the eects of transcription on repair are more pronounced at low levels of DNA damage (Vrieling et al., 1989 (Vrieling et al., , 1991 . Since much higher levels of DNA damage are typically employed for repair assays than for mutation assays, this may be the reason that the strand bias of mutation is much more pronounced than the strand bias of repair. For example, 90% of G to T transversions in the p53 gene occur in the nontranscribed strand (Greenblatt et al., 1994) , however, we observed only 2 ± 4-fold dierence in repair between the two strands. Our results show that BPDE adducts are removed two to four times faster from the transcribed strand than from the nontranscribed strand of the p53 gene. This result is consistent with the hypothesis that the process of transcription may facilitate nucleotide excision repair (Hanawalt, 1994; Hanawalt et al., 1994) . However, our results also demonstrate that repair eciency is DNA sequence-dependent, and that it is more variable in the nontranscribed strand than in the transcribed strand of the p53 gene. Transcriptioncoupled nucleotide excision repair may have equal accessibility to all BPDE-DNA adducts in the transcribed strand owing to sequence-indendent blockage of RNA polymerase at these adducts.
Although codon 245 of the p53 gene is a mutational hotspot in human cancer (including lung cancer), no strong BPDE adduct formation is found at this site on either the transcribed or nontranscribed strand using the UvrABC-LMPCR method. However, when BPDE adducts are assayed directly by UvrABC in BPDE modi®ed puri®ed p53 DNA without using the LMPCR technique, a high level of BPDE adducts is found at codon 245 (data not shown). These results indicate that our failure to detect BPDE adduct formation at codon 245 using the UvrABC-LMPCR method is probably not due to inability of UvrABC nuclease to cut adducts formed at this sequence, but rather, may be a consequence of either the DNA polymerase being unable to fully extend the UvrABC incised DNA or this fully extended DNA being refractory to ligation.
Although BPDE alkylates the guanine residue at codon 156(-CGC-as strongly as the one at codon 157 (-GTC-) in the nontranscribed strand, and the BPDE adducts formed at both these sequences are repaired with an equally slow rate (Figure 1 and 4) , codon 157 is a mutational hotspot in human lung cancer but codon 156 is not (Greenblatt et al., 1994; Harris, 1996) . In fact, none of the -CGC-sites, including codon 175, in the p53 gene are hotspots for mutation in lung cancer (Greenblatt et al., 1994; Harris, 1996) . Possible explanations for these results are: (1) BPDE adducts formed at -CGC-sequence may allow only a very low probability of translesion DNA synthesis and/or a very high ®delity of translesion DNA synthesis; (2) the amino acid change resulting from the G to T transversion occurring at codon 156 may have little eect on p53 function; in fact, only one G to T transversion is found at this codon in all cancers combined (Greenblatt et al., 1994) . Further studies are needed to test these possibilities. In previous work, repair of BPDE adducts was found to be sequence-dependent in the human HPRT gene and slow repair of speci®c positions in the gene was correlated with mutational hotspots (Wei et al., 1995) . Similarly, it has been shown that U.V.-induced cyclobutane pyrimidine dimers are repaired slowly at skin cancer mutational hotspots in the p53 gene (Tornaletti and Pfeifer, 1994) . The current results provide another example showing that both DNA damage and repair rates are important determinants of sequence-dependent mutation rates in human genes.
Materials and methods

Cell culture and BPDE treatment
Normal human ®broblasts were grown under standard conditions (Denissenko et al., 1996 (Denissenko et al., , 1997 . Cells growing at con¯uency were treated with BPDE (2 mM) for 30 min; after various incubation times cells were harvested and DNA isolated. Methods used for BPDE treatment and DNA isolation were the same as previously described (Denissenko et al., 1996 (Denissenko et al., , 1997 . No DNA replication was observed under these conditions (Venkatachalam et al., 1995) . It has been well established that the guanine adducts are the major adducts formed in cultured cells or DNA treated with racemic mixtures of BPDE, and 80 to 90% of the guanine adducts are the (+) optical isomers (MacLeod & Tang, 1985; MacLeod et al., 1988; Stevens et al., 1985) .
Treatment with UvrABC
Uvr proteins were puri®ed as described (Tang, 1996) . Puri®ed DNA was treated with an excess of UvrABC (a tenfold molar excess of protein over 10 4 nucleotides of DNA) as described (Tang, 1996) . Under the reaction conditions used, cleavage at BPDE-DNA adducts by UvrABC nucleases is quantitative. After UvrABC reaction, the Uvr proteins were removed by phenol extractions followed by diethyl ether extractions, and DNA was ethanol precipitated and resuspended in TE solution (1 mM Tris-HCl pH 8.0 and 0.1 mM EDTA).
Ligation-mediated PCR (LMPCR) and quantitations
The conditions and oligonucleotide primers used for LMPCR of the human p53 gene are described elsewhere (Tornaletti et al., 1993; Tornaletti & Pfeifer, 1994) . After reaction the ampli®ed DNAs were separated by denaturing polyacrylamide gel electrophoresis, electroblotted to a nylon membrane, and then hybridized with 32 P-labeled probes. The nylon membranes were exposed to a PhosphorImager (Molecular Dynamics, Sunnyvale, CA). Radioactivity was determined in all BPDE-speci®c bands of the sequencing gel that could be resolved and showed a quanti®able signal after substraction of background values.
Abbreviations BP, benzo[a]pyrene; BPDE, (+) anti-7b,8a-dihydroxy-9a, 10a-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene; LMPCR, ligation-mediated polymerase chain reaction; EDTA, ethylenediaminetetraacetic acid; HPRT, hypoxanthine-guanine phosphoribosyltransferase; DHFR, dihydrofolate reductase; APRT, adenine phosphoribosyltransferase. Figure 4 Quantitation of the rates of repair of BPDE adducts in the nontranscribed strand (upper) and transcribed strand (lower) along exons 5, 7, and 8 of the p53 gene. Repair rates, determined as the time at which 50% of the BPDE signal was removed, were estimated for each position with a visible signal above background from autoradiographs such as those shown in Figures 1 ±  3 . Background values (from the 0 mM BPDE+UvrABC lanes) were substracted. A repair time course was established for each position, and the time at which 50% of the initial damage was removed was then determined from this curve. The rates of repair at each site are represented by vertical columns. These data represent the average of two to three experiments for each exon and DNA strand
